Antenatal noninvasive DNA testing: Clinical experience and impact

American Journal of Perinatology

Volumn 31, Issue 7, 2014, Pages 577-582

  Ferres, Millie A ^a   Hui, Lisa ^b,c   Bianchi, Diana W ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MERCY HOSPITAL FOR WOMEN   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

cell free fetal DNA; NIDT; NIPD; noninvasive prenatal testing; pregnancy; prenatal screening

Indexed keywords

DNA;

ANEUPLOIDY; AUTOSOMAL DISORDER; BIOINFORMATICS; CELL FREE SYSTEM; CHROMOSOME ABERRATION; CHROMOSOME DISORDER; CLINICAL ASSESSMENT; DNA SCREENING; FETUS; FETUS MONITORING; GENOME ANALYSIS; HUMAN; HUMAN GENOME; MATERNAL BLOOD; MATERNAL PLASMA; MEDICAL TECHNOLOGY; NON INVASIVE PROCEDURE; NONINVASIVE DNA TESTING; POLYMERASE CHAIN REACTION; PRENATAL DIAGNOSIS; PRENATAL SCREENING; PRIORITY JOURNAL; REVIEW; RHESUS INCOMPATIBILITY; SINGLE NUCLEOTIDE POLYMORPHISM; BLOOD; CHROMOSOME DISORDERS; FEMALE; GENETIC SCREENING; PREGNANCY; PROCEDURES;

ANEUPLOIDY; CHROMOSOME DISORDERS; DNA; FEMALE; GENETIC TESTING; HUMANS; POLYMERASE CHAIN REACTION; PREGNANCY; PRENATAL DIAGNOSIS;

EID: 84903301148     PISSN: 07351631     EISSN: 10988785     Source Type: Journal    
DOI: 10.1055/s-0034-1371706     Document Type: Review

References (50)

1. Lo Y. M., Corbetta N., Chamberlain P. F., et al. Presence of fetal DNA in maternal plasma and serum. Lancet: 1997; 350 9076 485 487 (Pubitemid 27343304)
2. Fan H. C., Quake S. R. Detection of aneuploidy with digital polymerase chain reaction. Anal Chem: 2007; 79 19 7576 7579 (Pubitemid 47606128)
3. Lo Y. M., Lun F. M., Chan K. C., et al. Digital PCR for the molecular detection of fetal chromosomal aneuploidy. Proc Natl Acad Sci U S A: 2007; 104 32 13116 13121 (Pubitemid 351737602)
4. Fan H. C., Blumenfeld Y. J., Chitkara U., Hudgins L., Quake S. R. Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood. Proc Natl Acad Sci U S A: 2008; 105 42 16266 16271
5. Chiu R. W., Chan K. C., Gao Y., et al. Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma. Proc Natl Acad Sci U S A: 2008; 105 51 20458 20463
6. Chiu R. W., Akolekar R., Zheng Y. W., et al. Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study. BMJ: 2011; 342 c7401
7. Ehrich M., Deciu C., Zwiefelhofer T., et al. Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting. Am J Obstet Gynecol: 2011; 204 3 e1 e11
8. Sehnert A. J., Rhees B., Comstock D., et al. Optimal detection of fetal chromosomal abnormalities by massively parallel DNA sequencing of cell-free fetal DNA from maternal blood. Clin Chem: 2011; 57 7 1042 1049
9. Palomaki G. E., Kloza E. M., Lambert-Messerlian G. M., et al. DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study. Genet Med: 2011; 13 11 913 920
10. Sparks A. B., Wang E. T., Struble C. A., et al. Selective analysis of cell-free DNA in maternal blood for evaluation of fetal trisomy. Prenat Diagn: 2012; 32 1 3 9
11. Palomaki G. E., Deciu C., Kloza E. M., et al. DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study. Genet Med: 2012; 14 3 296 305
12. Bianchi D. W., Platt L. D., Goldberg J. D., Abuhamad A. Z., Sehnert A. J., Rava R. P.; MatErnal BLood IS Source to Accurately diagnose fetal aneuploidy (MELISSA) Study Group. Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing. Obstet Gynecol: 2012; 119 5 890 901
13. Ashoor G., Syngelaki A., Wagner M., Birdir C., Nicolaides K. H. Chromosome-selective sequencing of maternal plasma cell-free DNA for first-trimester detection of trisomy 21 and trisomy 18. Am J Obstet Gynecol: 2012; 206 4 e1 e5
14. Sparks A. B., Struble C. A., Wang E. T., Song K., Oliphant A. Noninvasive prenatal detection and selective analysis of cell-free DNA obtained from maternal blood: evaluation for trisomy 21 and trisomy 18. Am J Obstet Gynecol: 2012; 206 4 e1 e9
15. Norton M. E., Brar H., Weiss J., et al. Non-Invasive Chromosomal Evaluation (NICE) Study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18. Am J Obstet Gynecol: 2012; 207 2 e1 e8
16. Dan S., Wang W., Ren J., et al. Clinical application of massively parallel sequencing-based prenatal noninvasive fetal trisomy test for trisomies 21 and 18 in 11,105 pregnancies with mixed risk factors. Prenat Diagn: 2012; 32 13 1225 1232
17. Bianchi D. W. From prenatal genomic diagnosis to fetal personalized medicine: progress and challenges. Nat Med: 2012; 18 7 1041 1051
18. Scheffer P. G., van der Schoot C. E., Page-Christiaens G. C., de Haas M. Noninvasive fetal blood group genotyping of rhesus D, c, E and of K in alloimmunised pregnant women: evaluation of a 7-year clinical experience. BJOG: 2011; 118 11 1340 1348
19. Clausen F. B., Christiansen M., Steffensen R., et al. Report of the first nationally implemented clinical routine screening for fetal RHD in D- pregnant women to ascertain the requirement for antenatal RhD prophylaxis. Transfusion: 2012; 52 4 752 758
20. Wikman A. T., Tiblad E., Karlsson A., Olsson M. L., Westgren M., Reilly M. Noninvasive single-exon fetal RHD determination in a routine screening program in early pregnancy. Obstet Gynecol: 2012; 120 2 Pt 1 227 234
21. Rijnders R. J., van der Schoot C. E., Bossers B., de Vroede M. A., Christiaens G. C. Fetal sex determination from maternal plasma in pregnancies at risk for congenital adrenal hyperplasia. Obstet Gynecol: 2001; 98 3 374 378
22. Santacroce R., Vecchione G., Tomaiyolo M., et al. Identification of fetal gender in maternal blood is a helpful tool in the prenatal diagnosis of haemophilia. Haemophilia: 2006; 12 4 417 422
23. Hill M., Lewis C., Jenkins L., Allen S., Elles R. G., Chitty L. S. Implementing noninvasive prenatal fetal sex determination using cell-free fetal DNA in the United Kingdom. Expert Opin Biol Ther: 2012; 12 01 S119 S126
24. Lo Y. M., Chan K. C., Sun H., et al. Maternal plasma DNA sequencing reveals the genome-wide genetic and mutational profile of the fetus. Sci Transl Med: 2010; 2 61 61ra91
25. Srinivasan A., Bianchi D. W., Huang H., Sehnert A. J., Rava R. P. Noninvasive detection of fetal subchromosome abnormalities via deep sequencing of maternal plasma. Am J Hum Genet: 2013; 92 2 167 176
26. Nicolaides K. H., Syngelaki A., Gil M., Atanasova V., Markova D. Validation of targeted sequencing of single-nucleotide polymorphisms for non-invasive prenatal aneuploidy testing of chromosomes 13, 18, 21, X and Y using targeted sequencing of polymorphic loci. Prenat Diagn: 2013; 33 575 579
27. Nicolaides K. H., Syngelaki A., Gil M. M., Quezada M. S., Zinevich Y. Validation of targeted sequencing of single-nucleotide polymorphisms for non-invasive prenatal detection of aneuploidy of chromosomes 13, 18, 21, X, and Y. Fetal Diagn Ther: 2013; (e-pub ahead of print). doi: 10.1159/000355655
28. Futch T., Spinosa J., Bhatt S., de Feo E., Rava R. P., Sehnert A. J. Initial clinical laboratory experience in noninvasive prenatal testing for fetal aneuploidy from maternal plasma DNA samples. Prenat Diagn: 2013; 33 6 569 574
29. Malone F. D., Canick J. A., Ball R. H., et al. First- and Second-Trimester Evaluation of Risk (FASTER) Research Consortium. First-trimester or second-trimester screening, or both, for Down's syndrome. N Engl J Med: 2005; 353 19 2001 2011 (Pubitemid 41609093)
30. Benn P., Borell A., Chiu R. W., et al. Position statement from the Aneuploidy Screening Committee on behalf of the Board of the International Society for Prenatal Diagnosis. Prenat Diagn: 2013; 33 7 622 629
31. The American College of Obstetricians and Gynecologists Committee of Genetics; The Society for Maternal Fetal Medicine Publications Committee Committee Opinion. No. 545: Noninvasive prenatal testing for fetal aneuploidy. Obstet Gynecol.: 2012; Dec; 120 6 1532 1534. doi: 10.1097/01.AOG.0000423819. 85283.f4
32. Fairbrother G., Johnson S., Musci T. J., Song K. Clinical experience of noninvasive prenatal testing with cell-free DNA for fetal trisomies 21, 18, and 13, in a general screening population. Prenat Diagn: 2013; 33 6 580 583
33. Song Y., Liu C., Qi H., Zhang Y., Bian X., Liu J. Noninvasive prenatal testing of fetal aneuploidies by massively parallel sequencing in a prospective Chinese population. Prenat Diagn: 2013; 33 7 700 706
34. Walsh J. M., Goldberg J. D. Fetal aneuploidy detection by maternal plasma DNA sequencing: a technology assessment. Prenat Diagn: 2013; 33 6 514 520
35. Srinivasan A., Bianchi D. W., Liao W., Sehnert A. J., Rava R. P. Maternal plasma DNA sequencing: effects of multiple gestation on aneuploidy detection and the relative cell-free fetal DNA (cffDNA) per fetus. Am J Obstet Gynecol: 2013; 208 S31
36. Nicolaides K. H., Syngelaki A., Ashoor G., Birdir C., Touzet G. Noninvasive prenatal testing for fetal trisomies in a routinely screened first-trimester population. Am J Obstet Gynecol: 2012; 207 5 e1 e6
37. Nicolaides K. H., Wright D., Poon L. C., Syngelaki A., Gil M. M. First-trimester contingent screening for trisomy 21 by biomarkers and maternal blood cell-free DNA testing. Ultrasound Obstet Gynecol: 2013; 42 1 41 50
38. Chetty S., Garabedian M. J., Norton M. E. Uptake of noninvasive prenatal testing (NIPT) in women following positive aneuploidy screening. Prenat Diagn: 2013; 33 6 542 546
39. Bianchi D., Wilkins-Haug L. Integration of noninvasive DNA testing for aneuploidy into prenatal care: what has happened since the rubber met the road? Clin Chem: 2014; 60 1 78 87
40. Hahnemann J. M., Vejerslev L. O. Accuracy of cytogenetic findings on chorionic villus sampling (CVS)-diagnostic consequences of CVS mosaicism and non-mosaic discrepancy in centres contributing to EUCROMIC 1986-1992. Prenat Diagn: 1997; 17 9 801 820 (Pubitemid 27384796)
41. Faas B. H., de Ligt J., Janssen I., et al. Non-invasive prenatal diagnosis of fetal aneuploidies using massively parallel sequencing-by-ligation and evidence that cell-free fetal DNA in the maternal plasma originates from cytotrophoblastic cells. Expert Opin Biol Ther: 2012; 12 01 S19 S26
42. Osborne C. M., Hardisty E., Devers P., et al. Discordant noninvasive prenatal testing results in a patient subsequently diagnosed with metastatic disease. Prenat Diagn: 2013; 33 6 609 611
43. Bianchi D. W., Prosen T., Platt L. D., et al. MatErnal BLood IS Source to Accurately diagnose fetal aneuploidy (MELISSA) Study Group. Massively parallel sequencing of maternal plasma DNA in 113 cases of fetal nuchal cystic hygroma. Obstet Gynecol: 2013; 121 5 1057 1062
44. Mazloom A. R., DŽakula Z., Oeth P., et al. Noninvasive prenatal detection of sex chromosomal aneuploidies by sequencing circulating cell-free DNA from maternal plasma. Prenat Diagn: 2013; 33 6 591 597
45. Samango-Sprouse C., Banjevic M., Ryan A., et al. SNP-based non-invasive prenatal testing detects sex chromosome aneuploidies with high accuracy. Prenat Diagn: 2013; 33 7 643 649
46. Guex N., Iseli C., Syngelaki A., et al. A robust second-generation genome-wide test for fetal aneuploidy based on shotgun sequencing cell-free DNA in maternal blood. Prenat Diagn: 2013; 33 7 707 710
47. Yu S. C., Jiang P., Choy K. W., et al. Noninvasive prenatal molecular karyotyping from maternal plasma. PLoS ONE: 2013; 8 4 e60968
48. Jensen T. J., Dzakula Z., Deciu C., van den Boom D., Ehrich M. Detection of microdeletion 22q11.2 in a fetus by next-generation sequencing of maternal plasma. Clin Chem: 2012; 58 7 1148 1151
49. Lench N., Barrett A., Fielding S., et al. The clinical implementation of non-invasive prenatal diagnosis for single-gene disorders: challenges and progress made. Prenat Diagn: 2013; 33 6 555 562
50. Snyder M. W., Simmons L. E., Kitzman J. O., et al. Noninvasive fetal genome sequencing: a primer. Prenat Diagn: 2013; 33 6 547 554